Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stack

Showing results (301-310 of 317) with videos related to

Pageof 32
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2012
Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesisChiara Grisanzio, Lillian Werner, David Takeda, et al.
Cancer Discovery|March 15, 2014
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanibNikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Head & Neck|August 20, 2020
Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophthalmology, nuclear medicine and endocrinologyMichael C Singer, Francis Marchal, Peter Angelos, et al.
Oncoimmunology|November 10, 2022
Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibodyJessica D Weaver, Edward C Stack, Joshua A Buggé, et al.
Genome Biology|June 5, 2013
The genome sequence of the most widely cultivated cacao type and its use to identify candidate genes regulating pod colorJuan C Motamayor, Keithanne Mockaitis, Jeremy Schmutz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinomaMarkus Riester, Lillian Werner, Joaquim Bellmunt, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 14, 2022
Evaluating the Rising Incidence of Thyroid Cancer and Thyroid Nodule Detection Modes: A Multinational, Multi-institutional AnalysisMirabelle Sajisevi, Lisa Caulley, Antoine Eskander, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 24, 2021
Trends in Diagnosis of Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features and Total Thyroidectomies for Patients With Papillary Thyroid NeoplasmsLisa Caulley, Antoine Eskander, Weining Yang, et al.
Journal for Immunotherapy of Cancer|May 17, 2020
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validationJanis M Taube, Guray Akturk, Michael Angelo, et al.
Head & Neck|March 11, 2022
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatmentDavid C Shonka, Alan Ho, Ashish V Chintakuntlawar, et al.
Pageof 32

Showing results (301-310 of 317) with videos related to

Sort By:
Pageof 32
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2012
Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesisChiara Grisanzio, Lillian Werner, David Takeda, et al.
Cancer Discovery|March 15, 2014
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanibNikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Head & Neck|August 20, 2020
Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophthalmology, nuclear medicine and endocrinologyMichael C Singer, Francis Marchal, Peter Angelos, et al.
Oncoimmunology|November 10, 2022
Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibodyJessica D Weaver, Edward C Stack, Joshua A Buggé, et al.
Genome Biology|June 5, 2013
The genome sequence of the most widely cultivated cacao type and its use to identify candidate genes regulating pod colorJuan C Motamayor, Keithanne Mockaitis, Jeremy Schmutz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinomaMarkus Riester, Lillian Werner, Joaquim Bellmunt, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 14, 2022
Evaluating the Rising Incidence of Thyroid Cancer and Thyroid Nodule Detection Modes: A Multinational, Multi-institutional AnalysisMirabelle Sajisevi, Lisa Caulley, Antoine Eskander, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 24, 2021
Trends in Diagnosis of Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features and Total Thyroidectomies for Patients With Papillary Thyroid NeoplasmsLisa Caulley, Antoine Eskander, Weining Yang, et al.
Journal for Immunotherapy of Cancer|May 17, 2020
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validationJanis M Taube, Guray Akturk, Michael Angelo, et al.
Head & Neck|March 11, 2022
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatmentDavid C Shonka, Alan Ho, Ashish V Chintakuntlawar, et al.
Pageof 32